Tatjana Antic

14PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer diagnosisHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 13, 2026
Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB-amplified renal cell carcinoma: a comprehensive study of 15 cases.

|Jun 06, 2026
NFE2L2-mutated urothelial carcinomas frequently show concomitant myxoid and squamous features and have high PD-L1 expression.

|May 11, 2026
Comprehensive analysis of six MED15::TFE3 renal cell carcinomas including two novel solid MED15::TFE3 renal cell carcinomas, highlighting their morphologic, immunohistochemical and molecular differences from their cystic counterparts.

|Feb 06, 2026
PAX8-positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles - A clinicopathologic study of 101 consecutive cases with next-generation sequencing in 20 cases.

Sarah Mae Lammert, Wendy Luo, Allen C Zhu

|Dec 16, 2025
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features.

Melissa Yuwono Tjota, Jung Woo Kwon, Pankhuri Wanjari

|Nov 26, 2025
MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors.

Jung Woo Kwon, Melissa Y Tjota, Tatjana Antic

Pageof 3

Frequent Collaborators

8 joint publications

Jung Woo Kwon

4 joint publications

Melissa Yuwono Tjota

2 joint publications

Wendy Luo

2 joint publications

Sarah Mae Lammert